Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report

BACKGROUND: Calcium channel blockers (CCB), the first accepted treatment, is effective only in a small number of idiopathic pulmonary arterial hypertension (I-PAH) patients with vasoreactivity [these patients are identified by a positive acute pulmonary vasoreactive test (AVT) response]. While the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirakawa, Kyoko, Aoki, Tatsuo, Tsuji, Akihiro, Ogo, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446687/
https://www.ncbi.nlm.nih.gov/pubmed/36072422
http://dx.doi.org/10.1093/ehjcr/ytac351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446687/
https://www.ncbi.nlm.nih.gov/pubmed/36072422
http://dx.doi.org/10.1093/ehjcr/ytac351

Ejemplares similares